Avanir Settles With Wockhart Over Planned Nuedexta Generic
Avanir Pharmaceuticals Inc. said Friday it has reached a settlement with Wockhardt Ltd. over its planned generic version of mental health drug Nuedexta, ending a patent infringement dispute in Delaware federal...To view the full article, register now.
Already a subscriber? Click here to view full article